PRJNA576073
RNA-seq results between the recurrent implantation failure (RIF) and control groups
From July 2017 to December 2018, 54 women (aged between 23 and 39 years) who were treated at the Reproductive Medicine Center of Affiliated Drum Tower Hospital were enrolled in this study. All women exhibited a regular menstrual cycle ranging from 28-33 days, and none of them received hormonal therapy in the last three months. The exclusion criteria included polycystic ovarian syndrome (PCOS), hydrosalpinx, endometriosis, adenomyosis, endometrial hyperplasia or endometrial polyps.